NCT02696915

Brief Summary

Fracture femur is a common injury which is associated with excruciating pain. Positioning for neuraxial blocks is always challenging because even slight overriding of the fracture ends is intensely painful .It can causing major patient distress which accompanied by well-known physiological sequelae such as sympathetic activation causing tachycardia, hypotension, and increased cardiac work that may compromise high-risk cardiac patients. Fascia iliaca compartment block is highly effective in blocking lateral cutaneous nerve of the thigh and femoral nerve. Fascia iliaca compartment block is not only easy to perform but it is also associated with minimal risk as the local anesthetic is injected at a safe distance from the femoral artery and femoral nerve. It is always safe to perform the fascia iliaca compartment block prior to spinal anesthesia as the patient can respond during administration of the local anesthetic and can prevent intra-neuronal injections

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 22, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 2, 2016

Completed
Last Updated

March 8, 2016

Status Verified

March 1, 2016

Enrollment Period

6 months

First QC Date

February 22, 2016

Last Update Submit

March 4, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain scores

    Pain was assessed using visual analogue score

    For 24 hours after performance the blockade

Secondary Outcomes (9)

  • Heart rate

    For 24 hours after performance the blockade

  • Blood pressure

    For 24 hours after performance the blockade

  • Peripheral oxygen saturation

    For 24 hours after performance the blockade

  • Time to performing spinal anesthesia

    For 30 min after placement of patient in the optimum position

  • Number of trials of dural puncture

    For 30 min after placement of patient in the optimum position

  • +4 more secondary outcomes

Study Arms (2)

Placebo

PLACEBO COMPARATOR

Patients received ultrasound guided fascia iliaca compartment block using 40 ml of saline 0.9%. Then intrathecal medications will be administered.

Drug: PlaceboDevice: Ultrasound guided fascia iliaca compartment blockDrug: Intrathecal medications (bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms)

Bupivacaine

ACTIVE COMPARATOR

Patients received ultrasound guided fascia iliaca compartment block using 40 ml of 0.25% bupivacaine. Then intrathecal medications will be administered.

Drug: BupivacaineDevice: Ultrasound guided fascia iliaca compartment blockDrug: Intrathecal medications (bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms)

Interventions

Patients received ultrasound guided fascial iliaca compartment blockade using normal saline 0.9%, 40 ml

Placebo

Patients received ultrasound guided fascial iliaca compartment blockade using bupivacaine 0.25%, 40 ml

Bupivacaine

Ultrasound guided fascia iliaca compartment block

BupivacainePlacebo

Intrathecal hyperbaric bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms

BupivacainePlacebo

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologist physical status I to III
  • Patients scheduled for fixation for proximal end femur fracture

You may not qualify if:

  • Patients refusal
  • Morbid obese patients (BMI\>40)
  • Bleeding diathesis
  • Previous femoral bypass surgery
  • Inguinal hernia
  • Inflammation/infection over injection site
  • Peripheral neuropathy
  • Allergy to local anesthetics agents used.
  • Severely altered consciousness level
  • Psychiatric disorders
  • Polytrauma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University Hospitals

Al Mansurah, DK, 050, Egypt

Location

Related Publications (1)

  • Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020 Nov 25;11(11):CD001159. doi: 10.1002/14651858.CD001159.pub3.

MeSH Terms

Conditions

Proximal Femoral Fractures

Interventions

Bupivacaine

Condition Hierarchy (Ancestors)

Femoral Neck FracturesHip FracturesFemoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Reem A El Sharkawy, MD

    Lecturer of Anesthesia and Surgical Intensive Care

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2016

First Posted

March 2, 2016

Study Start

January 1, 2015

Primary Completion

July 1, 2015

Study Completion

August 1, 2015

Last Updated

March 8, 2016

Record last verified: 2016-03

Locations